-
-
Call more information
660-596-2224 -
ASA Monitor November 2022, Vol. 86, 41–42. APSF comments on criminalization of medical errors In June, MedPage Today reported on the Anesthesia Patient Safety Foundation (APSF) statement opposing the criminalization of medical errors in response to the conviction of a Tennessee nurse after a patient died as the result of a medication error and failure […]
Read MoreAuthors: Adam Striker, MD, FASA et al ASA Monitor November 2022, Vol. 86, 28–29. Building Long-Term Communication Success is the final subject in a four-part article series that provides more information about ASA’s Enhancing Patient Communications Program. ASA has received positive feedback on the guidance in our Enhancing Patient Communications Program toolkit, specifically its importance. The […]
Read MoreAUTHORS: De Biasio, Justin C. MD et al Anesthesia & Analgesia: June 2020 – Volume 130 – Issue 6 – p 1462-1473 Abstract Traditional approaches to clinical risk assessment utilize age as a marker of increased vulnerability to stress. Relatively recent advancements in the study of aging have led to the concept of the frailty syndrome, […]
Read MoreASA Monitor November 2022, Vol. 86, 17. According to recent recommendations from an ASA expert panel, which of the following examinations is MOST likely a primary application of diagnostic point-of-care ultrasound (POCUS) for anesthesiologists? □ (A) Airway □ (B) Musculoskeletal □ (C) Focused assessment with sonography in trauma (FAST) The use of POCUS has been gaining momentum since the […]
Read MoreASA Monitor November 2022, Vol. 86, 13. A patient with opioid use disorder is receiving buprenorphine. Treatment adherence is monitored using urine drug testing. Detection of which of the following in this patient’s urine sample would MOST likely indicate that it had been adulterated? □ (A) Buprenorphine □ (B) Low levels of norbuprenorphine □ (C) Low levels of thebaine […]
Read More